LobbyingAtrium Therapeutics lobbying by quarter
Atrium Therapeutics RNA's latest lobbying report covers Q2 2026, at $80K. Its first report covers Q1 2026; the issues it reports most are Health Issues.
Atrium TherapeuticsRNA
- Latest quarter
- $80K
- Q2 2026 · 1 reports
- Last 12 months
- $110K
- Last 2 quarters
- vs last quarter
- +166.7%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $30K | 1 |
| Q2 2026 | $80K | 1 |
Policy issues the reports name
- Health issues2 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ferox Strategies | $110K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CRISTINA ANTELO | Legal Fellow, Senate Democratic Steering Committee. | Q1 2026 |
| DEBRA DIXON | Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice | Q1 2026 |
| MARK WILLIAMS | Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson. | Q1 2026 |
| MICHAEL TAGGART | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Ferox Strategies | $80K |
| 04/17for Q1 | Ferox Strategies | $30K |
| 03/26for Q1 | Ferox Strategies | Under $5,000 |